Skip to main content

LadRx Corp

LADXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000799698

LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding LadRx Corp changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of LADX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders23+1
Shares45.1K59.4K+14.3K (+31.7%)
Value$23.0K$20.0K−$3.00K (−13.0%)

New holders (1)

Institutions that held LadRx Corp at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to LADX in Q1 2022
InstitutionSharesValue% of portfolio
First Heartland Consultants, Inc.14,300$4.00K0.00%

Sold out (0)

Institutions that held LadRx Corp at the end of Q4 2021 and filed for Q1 2022 without it.

None.